Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Exchange Rate Effect (2023 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Exchange Rate Effect for 3 consecutive years, with $64000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Exchange Rate Effect fell 93.45% to $64000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $87000.0, a 4250.0% increase, with the full-year FY2025 number at $87000.0, up 4250.0% from a year prior.
  • Exchange Rate Effect was $64000.0 for Q4 2025 at Rhythm Pharmaceuticals, down from $304000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $977000.0 in Q4 2024 to a low of -$603000.0 in Q3 2024.
  • A 3-year average of -$4416.7 and a median of -$36500.0 in 2024 define the central range for Exchange Rate Effect.
  • Biggest YoY gain for Exchange Rate Effect was 608.85% in 2024; the steepest drop was 883.12% in 2024.
  • Rhythm Pharmaceuticals' Exchange Rate Effect stood at -$192000.0 in 2023, then soared by 608.85% to $977000.0 in 2024, then crashed by 93.45% to $64000.0 in 2025.
  • Per Business Quant, the three most recent readings for RYTM's Exchange Rate Effect are $64000.0 (Q4 2025), $304000.0 (Q3 2025), and -$279000.0 (Q2 2025).